Compare Adaptive Biotechnologies Corp (ADPT) vs Apollo Global Management Ord Shs (APO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Apollo Global Management Ord Shs — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Apollo Global Management Ord Shs trades at $118.02 (market cap $68.80B). The key difference: Apollo Global Management Ord Shs is far larger — about 20.7× Adaptive Biotechnologies Corp's market cap, and Apollo Global Management Ord Shs pays a 1.89% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | APO | |
|---|---|---|
Market Cap | $3.33B | $68.80B |
Sector | Health | Financials |
52-Week High | $22.37 | $156.05 |
52-Week Low | $10.24 | $100.30 |
Enterprise Value | $3.19B | -$168.77B |
Dividend Yield | — | 1.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Apollo Global Management Ord Shs
Apollo Global Management Inc is an alternative investment manager. It serves various sectors such as chemicals, manufacturing and industrial, natural resources, consumer and retail, consumer services, business services, financial services, leisure, and media and telecom and technology. The company operates in three business segments that are Private Equity, Credit, and Real Assets. It generates maximum revenue from the Credit segment in the form of fees. The credit segment primarily invests in non-control corporate and structured debt instruments including performing, stressed and distressed instruments across the capital structure. It also includes Corporate Credit
Read more on APO →
